Prostate cancer aggressiveness locus on chromosome segment 19q12-q13.1 identified by linkage and allelic imbalance studies

Genes Chromosomes and Cancer

Volumn 36, Issue 4, 2003, Pages 332-339

  Neville, Phillippa J ^a   Conti, David V ^b   Krumroy, Lisa M ^a   Catalona, William J ^c   Suarez, Brian K ^d   Witte, John S ^b   Casey, Graham ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WASHINGTON UNIVERSITY   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALLELIC IMBALANCE; ARTICLE; CHROMOSOME 19Q; CONTROLLED STUDY; DATA ANALYSIS; FAMILIAL DISEASE; FAMILY HISTORY; GENE LOCUS; GENE MAPPING; GENETIC ANALYSIS; GENETIC LINKAGE; GENETIC MARKER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; SCORING SYSTEM;

AGED; ALLELIC IMBALANCE; CHROMOSOME MAPPING; CHROMOSOMES, HUMAN, PAIR 19; GENETIC MARKERS; HUMANS; LINKAGE (GENETICS); MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PARAFFIN EMBEDDING; PROSTATIC NEOPLASMS;

EID: 0037376366     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.10165     Document Type: Article

References (45)

1. American Cancer Society. 2002. Cancer facts and figures 2002. Atlanta, GA: American Cancer Society.
2. Astbury C, Jackson-Cook CK, Culp SH, Paisley TE, Ware JL. 2001. Suppression of tumorigenicity in the human prostate cancer cell line M12 via microcell-mediated restoration of chromosome 19. Genes Chromosomes Cancer 31:143-155.
3. Bednarek AK, Keck-Waggoner CL, Daniel RL, Laflin KJ, Bergsagel PL, Kiguchi K, Brenner AJ, Aldaz CM. 2001. WWOX, the FRA16D gene, behaves as a suppressor of tumor growth. Cancer Res 61:8068-8073.
4. Belge G, Rippe V, Meiboom M, Drieschner N, Garcia E, Bullerdiek J. 2001. Delineation of a 150-kb breakpoint cluster in benign thyroid tumors with 19q13.4 aberrations. Cytogenet Cell Genet 93:48-51.
5. Bockmuhl U, Wolf G, Schmidt S, Schwendel A, Jahnke V, Dietel M, Petersen I. 1998. Genomic alterations associated with malignancy in head and neck cancer. Head Neck 20:145-151.
6. Curtis LJ, Li Y, Gerbault-Seureau M, Kuick R, Dutrillaux AM, Goubin G, Fawcett J, Cram S, Dutrillaux B, Hanash S, Muleris M. 1998. Amplification of DNA sequences from chromosome 19q13.1 in human pancreatic cell lines. Genomics 53:42-55.
7. Devilee P, van Vliet M, Bardoel A, Kievits T, Kuipers-Dijkshoorn N, Pearson PL, Cornelisse CJ. 1991. Frequent somatic imbalance of marker alleles for chromosome 1 in human primary breast carcinoma. Cancer Res 51:1020-1025.
8. Elston RC, Buxbaum S, Jacobs KB, Olson JM. 2000. Haseman and Elston revisited. Genet Epidemiol 19:1-17.
9. Gao AC, Lou W, Ichikawa T, Denmeade SR, Barrett JC, Isaacs JT. 1999. Suppression of the tumorigenicity of prostatic cancer cells by gene(s) located on human chromosome 19p13.1-13.2. Prostate 38:46-54.
10. Goyal J, Smith KM, Cowan JM, Wazer DE, Lee SW, Band V. 1998. The role for NES1 serine protease as a novel tumor suppressor. Cancer Res 58:4782-4786.
11. Harach HR, Lesueur F, Amati P, Brown A, Canzian F, Kraimps JL, Levillain P, Menet E, Romeo G, Bonneau D. 1999. Histology of familial thyroid tumours linked to a gene mapping to chromosome 19p13.2. J Pathol 189:387-393.
12. Harvey TJ, Hooper JD, Myers SA, Stephenson SA, Ashworth LK, Clements JA. 2000. Tissue-specific expression patterns and fine mapping of the human kallikrein (KLK) locus on proximal 19q13.4. J Biol Chem 275:37397-37406.
13. Hemminki A, Tomlinson I, Markie D, Jarvinen H, Sistonen P, Bjorkqvist AM, Knuutila S, Salovaara R, Bodmer W, Shibata D, de la Chapelle A, Aaltonen LA. 1997. Localization of a susceptibility locus for Peutz-Jeghers syndrome to 19p using comparative genomic hybridization and targeted linkage analysis. Nat Genet 15:87-90.
14. Hemminki A, Markie D, Tomlinson I, Avizienyte E, Roth S, Loukola A, Bignell G, Warren W, Aminoff M, Hoglund P, Jarvinen H, Kristo P, Pelin K, Ridanpaa M, Salovaara R, Toro T, Bodmer W, Olschwang S, Olsen AS, Stratton MR, de la Chapelle A, Aaltonen LA. 1998. A serine/threonine kinase gene defective in Peutz-Jeghers syndrome. Nature 391:184-187.
15. Hoglund NI, Gorunova L, Andren-Sandberg A, Dawiskiba S, Mitelman F, Johansson B. 1998. Cytogenetic and fluorescence in situ hybridization analyses of chromosome 19 aberrations in pancreatic carcinomas: frequent loss of 19p13.3 and gain of 19q13.1-13.2. Genes Chromosomes Cancer 21:8-16.
16. Jarrous N, Eder PS, Wesolowski D, Altman S. 1999. Rpp14 and Rpp29, two protein subunits of human ribonuclease P. RNA 5:153-157.
17. Jenne DE, Reimann H, Nezu J, Friedel W, Loff S, Jeschke R, Muller O, Back W, Zimmer M. 1998. Peutz-Jeghers syndrome is caused by mutations in a novel serine threonine kinase. Nat Genet 18:38-43.
18. Kitamura Y, Shimizu K, Tanaka S, Ito K, Emi M. 2000. Allelotyping of anaplastic thyroid carcinoma: frequent allelic losses on 1q, 9p, 11, 17, 19p, and 22q. Genes Chromosomes Cancer 27:244-251.
19. Kupelian PA, Klein EA, Witte JS, Kupelian VA, Suh JH. 1997. Familial prostate cancer: a different disease? J Urol 158:2197-2201.
20. Le Merrer M, Legeai-Maller L, Jeannin PM, Horsthemke B, Schinzel A, Plauchu H, Toutain A, Achard F, Munnich A, Maroteaux P. 1994. A gene for hereditary multiple exostoses maps to chromosome 19p. Hum Mol Genet 3:717-722.
21. Lin L, Prescott MS, Zhu Z, Singh P, Chun SY, Kuick RD, Hanash SM, Orringer MB, Glover TW, Beer DG. 2000. Identification and characterization of a 19q12 amplicon in esophageal adenocarcinomas reveals cyclin E as the best candidate gene for this amplicon. Cancer Res 60:7021-7027.
22. McDonald JM, Douglass EC, Fisher R, Geiser CF, Krill CE, Strong LC, Virshup D, Huff V. 1998. Linkage of familial Wilms' tumor predisposition to chromosome 19 and a two-locus model for the etiology of familial tumors. Cancer Res 58:1387-1390.
23. Mehenni H, Blouin JL, Radhakrishna U, Bhardwaj SS, Bhardwaj K, Dixit VB, Richards KF, Bermejo-Fenoll A, Leal AS, Raval RC, Antonarakis SE. 1997. Peutz-Jeghers syndrome: confirmation of linkage to chromosome 19p13.3 and identification of a potential second locus, on 19q13.4. Am J Hum Genet 61:1327-1334.
24. Mora J, Cheung NK, Chen L, Qin J, Gerald W. 2001. Loss of heterozygosity at 19q13.3 is associated with locally aggressive neuroblastoma. Clin Cancer Res 7:1358-1361.
25. Nelson PS, Gan L, Ferguson C, Moss P, Gelinas R, Hood L, Wang K. 1999. Molecular cloning and characterization of prostase, an androgen-regulated serine protease with prostate-restricted expression. Proc Natl Acad Sci USA 96:3114-3119.
26. Neville PJ, Conti DV, Paris PL, Levin H, Catalona WJ, Suarez BK, Witte JS, Casey G. 2002. Prostate cancer aggressiveness locus on chromosome 7q32-q33 identified by linkage and allelic imbalance studies. Neoplasia 4:424-431.
27. Nupponen NN, Kakkola L, Koivisto P, Visakorpi T. 1998. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 153:141-148.
28. Paige AJ, Taylor KJ, Stewart A, Sgouros JG, Gabra H, Sellar GC, Smyth JF, Porteus DJ, Watson JE. 2000. A 700-kb physical map of a region of 16q23.2 homozygously deleted in multiple cancers and spanning the common fragile site FRA16D. Cancer Res 60:1690-1697.
29. Paris PL, Witte JS, Kupelian PA, Levin H, Klein EA, Catalona WJ, Casey G. 2000. Identification and fine mapping of a region showing a high frequency of allelic imbalance on chromosome 16q23.2 that corresponds to a prostate cancer susceptibility locus. Cancer Res 60:3645-3649.
30. Plummer SJ, Paris MJ, Myles J, Tubbs R, Crowe J, Casey G. 1997. Four regions of allelic imbalance on 17q12-qter associated with high-grade breast tumors. Genes Chromosomes Cancer 20:354-362.
31. Riegman PH, Vlietstra RJ, Klaassen P, van der Korput JA, Geurts van Kessel A, Romijn JC, Trapman J. 1989. The prostate-specific antigen gene and the human glandular kallikrein-1 gene are tandemly located on chromosome 19. FEBS Lett 247:123-126.
32. Sakakura C, Mori T, Sakabe T, Ariyama Y, Shinomiya T, Date K, Hagiwara A, Yamaguchi T, Takahashi T, Nakamura Y, Abe T, Inazawa J. 1999. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 24:299-305.
33. Scardino PT. 1989. Early detection of prostate cancer. Urol Clin North Am 16:635-655.
34. Shang E, Wang X, Huang J, Yoshida W, Kuroiwa A, Wolgemuth DJ. 2000. Murine Myak, a member of a family of yeast YAK1-related genes, is highly expressed in hormonally modulated epithelia in the reproductive system and in the embryonic central nervous system. Mol Reprod Dev 55:372-378.
35. Smith JS, Tachibana I, Lee HK, Qian J, Pohl U, Mohrenweiser HW, Borell TJ, Hosek SM, Soderberg CL, von Deimling A, Perry A, Scheithauer BW, Louis DN, Jenkins RB. 2000. Mapping of the chromosome 19 q-arm glioma tumor suppressor gene using fluorescence in situ hybridization and novel microsatellite markers. Genes Chromosomes Cancer 29:16-25.
36. Sutherland GR, Baker E, Hyland VJ, Callen DF, Close JA, Tregear GW, Evans BA, Richards RI. 1988. Human prostate-specific antigen (APS) is a member of the glandular kallikrein gene family at 19q13. Cytogenet Cell Genet 48:205-207.
37. Sutherland GR, Parslow MI, Baker E. 1985. New classes of fragile sites induced by 5-azacytidine and bromodeoxyuridine. Hum Genet 69:233-237.
38. van Eenennaam H, Pruijn GJ, van Venrooij WJ. 1999. hPop4: a new protein subunit of the human RNase MRP and RNase P ribonucleoprotein complexes. Nucleic Acids Res 27:2465-2472.
39. Wise CA, Clines GA, Massa H, Trask BJ, Lovett M. 1997. Identification and localization of the gene for EXTL, a third member of the multiple exostoses gene family. Genome Res 7:10-16.
40. Witte JS, Goddard KA, Conti DV, Elston RC, Lin J, Suarez BK, Broman KW, Burmester JK, Weber JL, Catalona WJ. 2000. Genomewide scan for prostate cancer-aggressiveness loci. Am J Hum Genet 67:92-99.
41. Yin BW, Lloyd KO. 2001. Molecular cloning of the CA125 ovarian cancer antigen: identification as a new mucin, MUC16. J Biol Chem 276:27371-27375.
42. Yousef GM, Magklara A, Diamandis EP. 2000. KLK12, is a novel serine protease and a new member of the human kallikrein gene family differential expression in breast cancer. Genomics 69:331-341.
43. Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP. 2001a. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res 61:3425-3431.
44. Yousef GM, Scorilas A, Jung K, Ashworrh LK, Diamandis EP. 2001b. Molecular cloning of the human kallikrein 15 gene (KLK15). Up-regulation in prostate cancer. J Biol Chem 276:53-61.
45. Zanotti KM, Hart WR, Kennedy AW, Belinson JL, Casey G. 1999. Allelic imbalance on chromosome 17p13 in borderline (low malignant potential) epithelial ovarian tumors. Int J Gynecol Pathol 18:247-253.